Mosaic ImmunoEngineering (CPMV) Debt Ratio (2024 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Debt Ratio of 20.35 for Q1 2026, up 894.95% year-over-year from 2.05 in Q1 2025, and up 102.3% quarter-over-quarter from 10.06 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Debt Ratio (2024 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Debt Ratio history runs 3 years deep, the most recent figure standing at 20.35 for Q1 2026.
- In Q1 2026, Debt Ratio rose 894.95% year-over-year to 20.35; the TTM figure through Mar 2026 stood at 20.35 (up 894.95% YoY), while the FY2025 annual figure was 10.06, up 612.26% from the prior year.
- Debt Ratio for Q1 2026 stood at 20.35, up from 10.06 in the prior quarter.
- The five-year high for Debt Ratio was 20.35 in Q1 2026, with the low at 1.41 in Q4 2024.
- The 3-year median for Debt Ratio is 3.54 (2025), against an average of 5.92.
- The sharpest annual moves came in 2025 and 2026: Debt Ratio retreated 24.19% in 2025, then jumped 894.95% in 2026.
- Mosaic ImmunoEngineering's Debt Ratio stood at 1.41 in 2024, then soared by 612.26% to 10.06 in 2025, then jumped by 102.3% to 20.35 in 2026.
- Business Quant data shows CPMV's Debt Ratio at 20.35 in Q1 2026, 10.06 in Q4 2025, and 3.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | 20.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.35 |
| Dec 31, 2025 | 10.06 |
| Sep 30, 2025 | 3.62 |
| Jun 30, 2025 | 3.47 |
| Mar 31, 2025 | 2.05 |
| Dec 31, 2024 | 1.41 |
| Sep 30, 2024 | 1.85 |
| Jun 30, 2024 | 4.57 |